|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q42047022
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000035.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q42047022
|
|
024
|
|
|
‡a
0000-0001-7512-7856
‡2
orcid
|
|
024
|
|
|
‡a
16637997400
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q42047022
|
|
100
|
0 |
|
‡a
Ian B. Malone
‡9
ast
‡9
es
‡9
sl
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Ian B. Malone
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Ian B. Malone
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
|
|
670
|
|
|
‡a
Author's A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance
|
|
670
|
|
|
‡a
Author's An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge
|
|
670
|
|
|
‡a
Author's Attenuation correction methods suitable for brain imaging with a PET/MRI scanner: a comparison of tissue atlas and template attenuation map approaches
|
|
670
|
|
|
‡a
Author's Automated template-based hippocampal segmentations from MRI: the effects of 1.5T or 3T field strength on accuracy
|
|
670
|
|
|
‡a
Author's Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study
|
|
670
|
|
|
‡a
Author's Charge transport and efficiency in photovoltaic devices based on polyfluorene blends
|
|
670
|
|
|
‡a
Author's Cognition at age 70: Life course predictors and associations with brain pathologies
|
|
670
|
|
|
‡a
Author's Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study
|
|
670
|
|
|
‡a
Author's Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement
|
|
670
|
|
|
‡a
Author's Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study
|
|
670
|
|
|
‡a
Author's Increased variability in reaction time is associated with amyloid beta pathology at age 70
|
|
670
|
|
|
‡a
Author's Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2
|
|
670
|
|
|
‡a
Author's MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset
|
|
670
|
|
|
‡a
Author's Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort
|
|
670
|
|
|
‡a
Author's Patterns of progressive atrophy vary with age in Alzheimer's disease patients.
|
|
670
|
|
|
‡a
Author's Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
|
|
670
|
|
|
‡a
Author's Profiles of white matter tract pathology in frontotemporal dementia
|
|
670
|
|
|
‡a
Author's Reversible frontotemporal brain sagging syndrome.
|
|
670
|
|
|
‡a
Author's Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
|
|
670
|
|
|
‡a
Author's Short-interval observational data to inform clinical trial design in Huntington's disease
|
|
670
|
|
|
‡a
Author's The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease
|
|
670
|
|
|
‡a
Author's The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study
|
|
670
|
|
|
‡a
Author's Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
|
|
670
|
|
|
‡a
Author's Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease
|
|
670
|
|
|
‡a
Author's White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy
|
|
670
|
|
|
‡a
Author's White matter tract signatures of the progressive aphasias
|
|
909
|
|
|
‡a
(scopus) 16637997400
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000175127856
‡9
1
|
|
919
|
|
|
‡a
patternsofprogressiveatrophyvarywithageinalzheimersdiseasepatients
‡A
Patterns of progressive atrophy vary with age in Alzheimer's disease patients.
‡9
1
|
|
919
|
|
|
‡a
presymptomaticatrophyinautosomaldominantalzheimersdiseaseaserialmristudy
‡A
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
‡9
1
|
|
919
|
|
|
‡a
profilesofwhitemattertractpathologyinfrontotemporaldementia
‡A
Profiles of white matter tract pathology in frontotemporal dementia
‡9
1
|
|
919
|
|
|
‡a
attenuationcorrectionmethodssuitableforbrainimagingwithapetmriscanneracomparisonoftissueatlasandtemplateattenuationmapapproaches
‡A
Attenuation correction methods suitable for brain imaging with a PET/MRI scanner: a comparison of tissue atlas and template attenuation map approaches
‡9
1
|
|
919
|
|
|
‡a
automatedtemplatebasedhippocampalsegmentationsfrommritheeffectsof15tor3tfieldstrengthonaccuracy
‡A
Automated template-based hippocampal segmentations from MRI: the effects of 1.5T or 3T field strength on accuracy
‡9
1
|
|
919
|
|
|
‡a
brainandhippocampalratesofatrophyinfamilialalzheimersdiseasemutationcarrierspreliminaryfindingsfromthedianstudy
‡A
Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study
‡9
1
|
|
919
|
|
|
‡a
chargetransportandefficiencyinphotovoltaicdevicesbasedonpolyfluoreneblends
‡A
Charge transport and efficiency in photovoltaic devices based on polyfluorene blends
‡9
1
|
|
919
|
|
|
‡a
cognitionatage70lifecoursepredictorsandassociationswithbrainpathologies
‡A
Cognition at age 70: Life course predictors and associations with brain pathologies
‡9
1
|
|
919
|
|
|
‡a
crosssectionalcerebralvolumetricdifferencesandassociationswithestimatedtimetoageatonsetinfamilialalzheimersdiseasefindingsfromthedianstudy
‡A
Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study
‡9
1
|
|
919
|
|
|
‡a
effectsofchangingfromnonacceleratedtoacceleratedmriforfollowupinbrainatrophymeasurement
‡A
Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement
‡9
1
|
|
919
|
|
|
‡a
miriadpublicreleaseofamultipletimepointalzheimersmrimagingdataset
‡A
MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset
‡9
1
|
|
919
|
|
|
‡a
olfactorytestingdoesnotpredictβamyloidmrimeasuresofneurodegenerationorvascularpathologyinthebritish1946birthcohort
‡A
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort
‡9
1
|
|
919
|
|
|
‡a
shortintervalobservationaldatatoinformclinicaltrialdesigninhuntingtonsdisease
‡A
Short-interval observational data to inform clinical trial design in Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
evaluationofmultimodalmultisiteneuroimagingmeasuresinhuntingtonsdiseasebaselineresultsfromthepaddingtonstudy
‡A
Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study
‡9
1
|
|
919
|
|
|
‡a
increasedvariabilityinreactiontimeisassociatedwithamyloidbetapathologyatage70
‡A
Increased variability in reaction time is associated with amyloid beta pathology at age 70
‡9
1
|
|
919
|
|
|
‡a
magneticresonanceimagingevidenceforpresymptomaticchangeinthalamusandcaudateinfamilialalzheimersdisease
‡A
Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
assessingatrophymeasurementtechniquesindementiaresultsfromthemiriadatrophychallenge
‡A
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge
‡9
1
|
|
919
|
|
|
‡a
unbiasedlongitudinalanalysisframeworkfortrackingwhitematterchangesusingdiffusiontensorimagingwithapplicationtoalzheimersdisease
‡A
An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
accurateautomaticestimationoftotalintracranialvolumeanuisancevariablewithlessnuisance
‡A
Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance
‡9
1
|
|
919
|
|
|
‡a
magneticresonanceimaginginalzheimersdiseaseneuroimaginginitiative2
‡A
Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2
‡9
1
|
|
919
|
|
|
‡a
voxelbasedmorphometrystudyofvolumetricmriinfamilialalzheimersdisease
‡A
A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
serumneurofilamentlightinfamilialalzheimerdiseaseamarkerofearlyneurodegeneration
‡A
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
‡9
1
|
|
919
|
|
|
‡a
comparisonofacceleratedandnonacceleratedmriscansforbrainvolumeandboundaryshiftintegralmeasuresofvolumechangeevidencefromtheadnidataset
‡A
A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
‡9
1
|
|
919
|
|
|
‡a
visuomotorintegrationdeficitsarecommontofamilialandsporadicpreclinicalalzheimersdisease
‡A
Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease
‡9
1
|
|
919
|
|
|
‡a
whitematterhyperintensitiesareassociatedwithdisproportionateprogressivehippocampalatrophy
‡A
White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy
‡9
1
|
|
919
|
|
|
‡a
importanceofgroupwiseregistrationintractbasedspatialstatisticsstudyofneurodegenerationasimulationstudyinalzheimersdisease
‡A
The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
patternofatrophyinfamilialalzheimerdiseasevolumetricmriresultsfromthedianstudy
‡A
The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study
‡9
1
|
|
919
|
|
|
‡a
whitemattertractsignaturesoftheprogressiveaphasias
‡A
White matter tract signatures of the progressive aphasias
‡9
1
|
|
919
|
|
|
‡a
vascularandalzheimersdiseasemarkersindependentlypredictbrainatrophyrateinalzheimersdiseaseneuroimaginginitiativecontrols
‡A
Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
‡9
1
|
|
919
|
|
|
‡a
reversiblefrontotemporalbrainsaggingsyndrome
‡A
Reversible frontotemporal brain sagging syndrome.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
DBC|87097962853565
|
|
996
|
|
|
‡2
ISNI|0000000038411359
|
|
996
|
|
|
‡2
LC|no2001041266
|
|
996
|
|
|
‡2
LC|no2009065370
|
|
996
|
|
|
‡2
LC|n 2008059298
|
|
996
|
|
|
‡2
ISNI|000000044435461X
|
|
996
|
|
|
‡2
BIBSYS|2113844
|
|
996
|
|
|
‡2
N6I|vtls000074568
|
|
996
|
|
|
‡2
RERO|A025833139
|
|
996
|
|
|
‡2
RERO|A003554927
|
|
996
|
|
|
‡2
BIBSYS|1653286950074
|
|
996
|
|
|
‡2
W2Z|1653286950074
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
